LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SRI
Stoneridge, Inc.
There isn't enough reported data to score SRI yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SRI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
SRI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SRI PE Valuation
SRI has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SRI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SRI's earnings to decline, with its revenue and profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over SRI on earnings, with more consistent year-over-year improvement.
SRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.76 | -$3.60 |
| Q2 2026 | -$4.29 | -$3.21 |
| Q1 2026 | -$4.44 | -$3.80 |
| Q4 2025 | -$3.70 | -$3.10 |
| Q3 2025 | -$1.16 | -$0.89 |
| Q2 2025 | -$1.08 | -1643% |
| Q1 2025 | -$0.64 | -$0.50 |
| Q4 2024 | -$0.60 | -$0.41 |
SRI lost $4.76 per share over the past year, a bigger loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $155.8M | -26% |
| Q2 2026 | $181.4M | -20% |
| Q1 2026 | $160.8M | -26% |
| Q4 2025 | $205.2M | -6% |
| Q3 2025 | $210.3M | -1.7% |
| Q2 2025 | $228M | -3.8% |
| Q1 2025 | $217.9M | -8.9% |
| Q4 2024 | $218.2M | -4.9% |
SRI's revenue has slid since its 2023 peak: $156M last quarter, down 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -14 points |
| Q2 2026 | -0.7% | +0.5 points |
| Q1 2026 | -5.6% | -4.1 points |
| Q4 2025 | -14% | -12 points |
| Q3 2025 | -1.6% | -1.7 points |
| Q2 2025 | -1.1% | -2.6 points |
| Q1 2025 | -1.5% | -1.6 points |
| Q4 2024 | -2% | -4.7 points |
SRI has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$236K | +$2.5M |
| Q2 2026 | $7.7M | +4.5% |
| Q1 2026 | -$12.3M | -356% |
| Q4 2025 | $2.6M | -81% |
| Q3 2025 | -$2.7M | -158% |
| Q2 2025 | $7.4M | +385% |
| Q1 2025 | $4.8M | +46% |
| Q4 2024 | $14M | +1897% |
SRI has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +143K shares |
| 1 year | +1.9% | +528K shares |
| 3 years | +2.4% | +653K shares |
| 5 years | +4.6% | +1.2M shares |
| Available history | +0.4% | +117K shares |
SRI has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5M |
| Q4 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
| Q2 2024 | -0.8x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -0.8x | Net Cash |
SRI has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.1 | Neutral |
| Stochastic | 9.0 | Oversold |
SRI's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SRI PE vs Consumer Cyclical Sector
| Metric | SRI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
SRI has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.92 | 14% below |
| 20 week MA | $6.68 | 24% below |
| 50 week MA | $6.70 | 24% below |
| 100 week MA | $6.37 | 20% below |
| 200 week MA | $11.5 | 56% below |
SRI is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.7 | $29.6 | -0.1% |
| 2021 | $29.6 | $18.7 | -37% |
| 2022 | $18.7 | $21.3 | +14% |
| 2023 | $21.3 | $19.6 | -8% |
| 2024 | $19.6 | $6.21 | -68% |
| 2025 | $6.21 | $5.69 | -8.4% |
| 2026 YTD | $5.69 | $5.09 | -11% |
SRI has the edge over LCID on returns for 2026, with the stronger performance.